Top

Reactions Weekly

Published in:

01-04-2024 | Checkpoint Inhibitors | Case report

Ipilimumab/Pembrolizumab

Adrenocorticotropic hormone deficiency and lack of efficacy

Published in: Reactions Weekly | Issue 1/2024

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Country of occurrence, reporter country and primary source country not stated. Author's communication details not available.

AO'Hare J, et al. Isolated ACTH Deficiency after Treatment with Immune- Checkpoint Inhibitors. Journal of the Endocrine Society 13 (Suppl.): Apr 2019. Available from: URL: https://dx.doi.org/10.1210/js.2019-MON-361 [abstract]

Title: Ipilimumab/Pembrolizumab
Adrenocorticotropic hormone deficiency and lack of efficacy
Publication date: 01-04-2024
Publisher: Springer International Publishing
Keywords: Checkpoint Inhibitors
Melanoma
Melanoma
Published in: Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-56889-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Ipilimumab/Pembrolizumab

Adrenocorticotropic hormone deficiency and lack of efficacy

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Immunosuppressant/zoledronic-acid

Immune-globulin

Lenalidomide

Selpercatinib

Alteplase

Busulfan/cyclophosphamide/fludarabine